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Abstract Feline vaccine associated fibrosarcomas are the
second most common skin tumor in cats. Methods of treat-
ment are: surgery, chemotherapy and radiotherapy. Never-
theless, the usage of cytostatics in feline vaccine associated
sarcoma therapy is limited due to their adverse side effects,
high toxicity and low biodistribution after i.v. injection.
Therefore, much research on new therapeutic drugs is being
conducted. In human medicine, the chick embryo chorioal-
lantoic membrane (CAM) model is used as a cheap and easy
to perform assay to assess new drug effectiveness in cancer
treatment. Various human cell lines have different tumors
growth on CAM. In veterinary medicine such model has not
been described yet. In the present article derivation of feline
vaccine associated fibrosarcoma cell line and its growth on
CAM is described. The cell line and the tumor grown were
confirmed by histopathological and immunohistochemical
examination. As far as we believe, this is the first attempt to
create such model, which may be used for further in vivo
studies in veterinary oncology.
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Introduction
Feline vaccine-associated fibrosarcomas are the second
most common kind of skin tumors found in cats. Predictive
factors are vaccination against rabies and feline leukemia
virus (FeLV) due to the aluminum adjuvant ions contained
in these vaccines (Madwell et al. 2001; Couto et al. 2002).
The exact mechanism of the formation of fibrosarcomas in
cats is unknown, but it is suspected that the overexpressed
inflammation of skin in the place of injection changes into
neoplasm. According to the latest reports the genetic predis-
position may also be important (Nambiar et al. 2001). It has
been proven that cats injected many times in the same place
(especially in the intrascapular region) are more likely to
develop tumors. Thus, according to the newest guidelines
published by the Vaccine Associated Feline Sarcoma Task
Force from the U.S. cats should be injected near to pelvic
limbs changing sides, because in severe cases leg amputa-
tions can be performed. Initially diagnosis is made based on
the history, clinical examination of the patient and results of
K. Zabielska (*) : R. Lechowski
Department of Small Animal Diseases with Clinic, Faculty of




M. Król :K. M. Pawłowski : T. Motyl
Department of Physiological Sciences,
Faculty of Veterinary Medicine,




Department of Animal Environment Biology, Faculty of Animal
Sciences, Warsaw University of Life Sciences - WULS,
Ciszewskiego 8,
02-786 Warsaw, Poland
I. Dolka :A. Żbikowski
Department of Pathology and Veterinary Diagnostics,




Vet Res Commun (2012) 36:227–233
DOI 10.1007/s11259-012-9535-9
a fine-needle aspiration biopsy of the tumor. The definitive
diagnosis is based on a histopathological examination of the
tumor after its surgical resection. Methods of treatment are:
surgery, chemotherapy and radiotherapy. Surgery is the first
method of treatment; however, not all cancers can be re-
moved surgically, depending on the type, the malignancy
level, the localization and size of the tumor and above all the
condition of the patient. The additional treatment is chemo-
therapy and radiotherapy. It has been proven that chemo-
therapeutic agents such as doxorubicin, cyclophosphamide
and vincristine show high efficiency against soft tissue
sarcomas, including feline vaccine associated fibrosarco-
mas. Unfortunately, the use of cytostatics in adjuvant ther-
apy of feline vaccine-associated fibrosarcomas is limited
due to their adverse side effects, high toxicity and low
biodistribution after intra venous (i.v.) injection (MacDonald
2009). New drugs, as e.g. nanoparticles conjuncted with
cytostatics are currently being tested (Brigger et al. 2002).
Animal models (most common rodent models) are used
during preclinical in vivo studies. In human medicine, the
chick embryo chorioallantoic membrane (CAM) model is
also used as a cheap and easy to perform assay to assess a
cancer’s ability to metastasis, pro- and anti- angiogenic
potential and to assess new drug’s effectiveness (Dagg et
al. 1956; Armstrong et al. 1982; Strum 1983; Ribatti et al.
2000; Vargas et al. 2007). As it has many advantages com-
paring with mouse model, we decided to create the first
CAM model in veterinary medicine. The main advantage
of this model is the ease of implementation and the faster
tumor growth compared to other animal models (eg. on
CAM it is 5–7 days, on rodent models about 3–6 weeks).
Moreover, it is more ethical and a relatively cheap model
and there is no need to keep animals. If experiments finish
before hatching, according to the European law (Directive
2010/63/EU of the European Parliament and of the Council
of 22 September 2010 on the protection of animals used for
scientific purposes) the bioethical commission’s approval is
not necessary. The only disadvantage is that the tumors exist
for only 7–10 days (because the chick embryo development
lasts 21 days and the tumor cells are usually implemented
between the 6th and the 8th day of the chick embryo cycle).
This model is well described for the human neuroblastoma
cell lines (IMR 32) (Balke et al. 2010) and human osteosar-
coma cell lines (HOS, MG63, MNNG-HOS, OST, SAOS,
SJSA1, U2OS, ZK58) (Mangieri et al. 2009). It has been
approved by the United States Food and Drug Administration
(FDA) as an alternative method for preclinical testing. That
model in veterinarymedicinemay simplify conducting in vivo
studies, enable better knowledge about biology of various
tumors and assess the effectiveness of different novel drugs.
Thus, the present study aimed to isolate a feline vaccine-
associated sarcoma cell line and to cultivate it on CAM. We
aimed to create a new model for further in vivo veterinary
oncologic studies. As far as we believe, this is the first study
concerning the use of CAM in veterinary medicine.
Materials and methods
Tumor sample
The tumor sample was obtained from an 8 years old feline
patient with a history and clinical signs typical for vaccine-
associated feline fibrosarcoma. The patient had been diag-
nosed for the recurrence of the vaccine-associated feline
fibrosarcoma in the intrascapular region - the same place
where the primary tumor was surgically removed 2 years
before. The fine-needle aspiration biopsy confirmed the
vaccine-associated fibrosarcoma. Blood tests and chest ra-
diograph were performed. The blood results were in the
reference value and no metastases to the lungs were found.
The patient was classified for surgery and a surgical resec-
tion was performed according to the standard procedure.
The histopathological examination of surgically removed
tumor sample confirmed the previously given diagnosis
(feline vaccine-associated fibrosarcoma).
Isolation of the feline vaccine-associated fibrosarcoma cell
line (FVAF1)
The procedure of cells isolation from tumor tissue has been
described previously (Pawłowski et al. 2009; Król et al. 2010).
Immediately after tumor resection the tumor was aseptically
collected to the Dulbecco’sModified EagleMedium (DMEM)
containing flask and was transported to the cell culture labo-
ratory. The tumor sample was then sliced and cultured over-
night in collagenase containing medium DMEM according to
the Limon et al. protocol (Limon et al. 1986) (modified by Dr
Eva Hellmen, Swedish University of Agricultural Sciences,
Sweden). The following day, the medium was centrifuged and
pellet was suspended in a fresh culture medium. The cells were
cultured under optimal conditions: a DMEM enriched with
10 % (v/v) heat-inactivated fetal bovine serum (FBS),
penicillin-streptomycin (50 IU mL–1), and fungizone
(2.5 mg mL−1) (reagents obtained from Sigma Aldrich,
USA), in an atmosphere of 5 % CO2 and 95 % humidified
air at 37 °C, and routinely sub-cultured every other day.
Histopathological and immunohistochemical examination
The tissue sample embedded in paraffin block was cut into
5 μm sections and baked in 37 °C overnight. After dewaxing
in xylene and rehydration in ethanol, for antigen retrieval, the
slides were placed in 0.02 M citrate buffer, pH 6.0 and boiled
in the decloaking chamber. The tumor type was established
based on the histopathological features of vaccine-associated
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feline sarcomas which have been previously described in the
literature (Goldschmidt and Hendrick 2002; Madwell et al.
2001; Vascellari et al. 2003), whereas the tumor grading was
based on the criteria proposed by Couto et al. (2002). The
feline vaccine-associated fibrosarcoma cells (FVAF1) were
cultured on Lab-Tek (Nunc Inc., USA) 4-chamber culture
slides and were then fixed with ethanol after 24 h. The
immunohistochemical examination of the expression of
vimentin, smooth muscle actin, desmin and cytokeratin was
performed on the tissue sample as well as on the FVAF1 cell
line to confirm the same expression of antibodies in tumor
cells as in the tissue sample. The usage of primary antibodies
for different fibrosarcomas, including feline fibrosarcomas,
both in cell lines and tissue samples, was described in many
previous studies (Vascellari et al. 2003; Madwell et al. 2001;
Goldschmidt and Hendrick 2002) and PhD thesis (“Untersu-
chungen zur Transkription vonWachstumsfaktoren und Zyto-
kinen an felinen Vakzinationsstellen” Löhberg-Grüne, 2009;
“Klonierung feliner Fibrosarkomzelllinien und deren zytoge-
netische Charakterisierung”Wasieri, 2009). The samples were
incubated in the Peroxidase Blocking Reagent (Dako, Den-
mark) for 10 min at room temperature prior to the antibody
incubation. After 30 min incubation in 5 % bovine serum
albumin (Sigma Aldrich, Germany), the following primary
antibodies were used (diluted in 1 % bovine serum): mono-
clonal mouse anti-human cytokeratin (Clone MNF116);
monoclonal mouse anti-human vimentin (Clone Vim 3B4);
monoclonal mouse anti-human actin (smooth muscle) (Clone
1A4); monoclonal mouse anti – human desmin (Clone D33)
all antibodies at the concentration 1:50, obtained from Dako
(Denmark). According to the manufacturer’s instructions the
slides were incubated with antibodies at +4 °C overnight or
1 h at room temperature. For the staining the anti-mouse
EnVision kits (Labelled Polymers consist of secondary anti-
rabbit antibodies conjugated with the HRP enzyme complex
obtained from Dako) was used. To develop the coloured
product, the 3,3′-Diaminobenzidine (DAB) substrate was used
(Dako). Finally, the haematoxylinwas used for nuclei counter-
staining. The staining without the use of primary antibodies
was done as a negative control for each immunohistochemical
analysis. The pictures were taken using Olympus microscopy
BX60 (Olympus, Germany).
The tumor grade was established according to the grading
scheme, previously adapted to the dog (Powers et al. 1995)
and recently applied to feline vaccine associated fibrosarco-
mas (Couto et al. 2002; Vascellari et al. 2003), basing on
cellular differentiation, presence and extension of necrosis
within the neoplasm and mitotic rate.
FVAF1 cell line growth on CAM
The new method of implementation of feline tumors cell
cultures was developed by modifying the method of
implementation of human tumors (eg. neuroma, osteosarco-
ma) in the chick embryos’ chorioallantoic membrane (Balke
et al. 2010; Mangieri et al. 2009).
The 30 chick embryos (Ross 308 line, Pankowski Jan
Poultry Hatchery, Poland) were held in the CO2 incubator
(SMA Coudelou ZA 37210, France) under standard condi-
tions (65 % humidity, 5 % CO2 and 37.5 °C) as soon as the
embryogenesis started. On the 5th day of incubation a
5 mm×5 mm ‘window’ was made in the eggshell on the
blunt end on each of the egg. The parchment-like membrane
was carefully taken out and a sterile silicon ring was put into
CAM of each egg in accordance to aseptic procedures.
Medium hard silicon rings, which are 7 mm in external
diameter, 5 mm in internal diameter and 2 mm thick, were
specially designed for this experiment and produced by
Zegir PTHU (Poland). They were sterilized before use.
The ‘window’ in the egg’s shell was closed using Polopor
(Viscoplast, Poland) - a special adhesive tape with high air
and water vapor. After 24 and 48 h eggs were candled to
check the vitality and estimate the mortality associated with
manual manipulation. The silicon rings were put into CAM
2 days before tumor cells inoculation to exclude the mortal-
ity of chick embryos caused by blood vessel damage and
possible overexpressed inflammatory reaction due to putting
silicon rings. Moreover, after those 2 days the silicon rings
were more stable in the CAM as the blood vessels spread
into it. On the 7th day of incubation FVAF1 cells (5×106
cells in 25 μl of medium per egg) were administered into 20
chick embryos. 7 chick embryos were used as a negative
control (inoculated only with 25 μl of medium (DMEM) per
egg). At this day, chick embryo’s vitality was 85 % (1 out of
20 chick embryos were alive, 3 were dead probably due to
mechanical manipulations connected with taking out the
parchment-like membrane and putting silicon rings in
CAM). Both tumor cells and medium were injected exactly
into the silicon rings. Then, the ‘window’ in the eggshell
were closed with the adhesive tape again. Eggs were can-
dled 24 and 48 h later to check their survival. On the 12th
day of incubation 17 out of 20 inoculated chick embryos
were alive and were examined with the video otoscope
(Welch Allyn MacroView™ Veterinary Otoscope 71032,
USA) for tumor growth. However, no tumor growth was
observed (phot.3). On the 16th day of the incubation 16
chick embryos were alive and tumor growth was ob-
served. To confirm growth of the injected tumor cells, a
histopathological examination of tumors was performed
on the 18th day of the incubation, according to the
procedures given above. We performed the histopatho-
logical examination on the day 18th day as the CAM
started to degenerate at the day 18–19. Until the end of
the experiment 5 out of 6 chick embryos used as a
negative control with medium alone were alive and
did not show any tumor grown.
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Results
Histopathological and immunohistochemical analysis
of the cell line FVAF1
The slides stained with haematoxylin-eosin showed the
presence of multinucleated giant cells, pleomorphic cells
with mild to marked atypia and mitotic figures. These find-
ings appear to be most closely related to vaccine -associated
feline sarcoma (VAFS) (Fig. 1a and b). Cell lines derived
from vaccine-associated feline sarcoma were strongly posi-
tive for vimentin (+++) (Fig. 2a), some cells were positive
for smooth muscle actin (+,+/−) (Fig. 2b), single cells pos-
itive for desmin (+,+/−) (Fig. 2c) and for cytokeratin (+/−)
(Fig. 2d). Strong positive staining for vimentin confirms the
mesenchymal origin of neoplastic cells.
Tumor sample growth on CAM
Feline vaccine associated fibrosarcoma growth on chick
embryo chorioallantoic membrane
The tumor growth was checked every 2 days since inocula-
tion. Positive tumor development was reported when tumor
angiogenesis was visible and when tumor size was of at
least 2 mm in diameter. On the 16th day of incubation a
tumor size of 5 mm (on average) in diameter was observed
(Fig. 3a, b, c and d). The capillary vessels growing into the
tumor were visible (Fig. 3c). The tumor had smooth surface,
ovoid to spherical shape and was strongly attached to the
CAM. It was located not exactly in the silicon ring, but a
few milimeters out of it, either the tumor cells had spread
through the vessels or the silicon ring position had slightly
moved during embryogenesis and growth of the CAM and
chick embryo.
Histopathological examination
The histopathological assessment of the tissue sample of
small solid mass within CAM showed that the tumor was
undifferentiated sarcoma (Fig. 4a and b). The mass was well
demarcated, but non-encapsulated. Histologically, sarcoma
consisted of pleomorphic, polyhedral, round or spindle-
shaped cells with variations in size and shape of nuclei,
nuclear hyperchromasia, prominent eosinophilic nucleoli,
scant to abundant eosinophilic cytoplasm and indistinct cell
borders. Some cells were bi- or trinucleated and some with
eccentrically placed nuclei which resembled vacuolated
cells. Neoplastic cells were mainly arranged without a spe-
cific pattern. Mitotic rate was low. Besides, the majority of
neoformed vessels were present. No areas of necrosis within
the tumor as well as no lymphocyte aggregates at the pe-
riphery of the mass were visible. Masson’s trichrome stain-
ing confirmed the mesenchymal components of this tumor
and allowed to evaluate the amount and the distribution of
collagen (Fig. 4c). According to the grading system on the
basis of cellular differentiation, mitotic rate, presence and
extension of necrosis, the sarcoma was classified as grade II.
Immunohistochemical examination
Immunohistochemical examination delineated the mesen-
chymal components of tumor. The samples were strong-
ly positive for vimentin (Fig. 5a). Some neoplastic cells
were stained with smooth muscle actin antibody. Addi-
tionally, anti-actin and anti-desmin antibody labelled the
walls of blood vessels (Fig. 5b and c). Neoplastic cells
did not react with cytokeratin, which confirmed the non-
epithelial origin of these cells (Fig. 5d). Only some foci
of presumptive squamous epithelial cells showed cyto-
keratin expression.
According to the Couto et al. grading system (Couto et al.
2002) the tumor was classified as grade II of malignancy.
Discussion
The only available commercial cell line of feline fibrosar-
coma is from NBL Cell Line Collection – a part of Amer-
ican Type Culture Collection (ATCC, designation FC 77.T)
and cannot be delivered to European countries (distributed
only within the United States). That is the reason why the
authors decided to isolate their own feline vaccine associat-
ed fibrosarcoma cell line (FVAF1), which gives the possi-
bility to further investigate on molecular level and to find
new methods of treatment.
Fig. 1 Feline vaccine-
associated sarcoma cells stained
with hematoxylin-eosin meth-
od. Multinucleated giant cells is
visible on Fig. 1. original mag-
nification 400×, and mitotic
figure (black arrow)
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Comparing the proposed model to rodent model the main
advantage of the CAM model is the fact that the experiment
can be repeated many times and a large amount of chick
embryos may be used in one time, which gives more reliable
results. It results from the fact that it is an in vivo animal
model that does not require the approval of a bioethic
committee in European countries. Performing the same
number of experiments and the same number of species on
rats would be rather impossible not only due to animal law
regulation but also for ethical reasons. Moreover, the tumor
growth in the presented model lasts 10 days, while on rodent
model from 3 to 6 weeks. Relatively fast tumor growth
makes this model easier to utilise.
Furthermore, it has the cognitive value showing possibil-
ity of feline vaccine associated fibrosarcoma growth on
CAM. According to the available data in the field, human
cancer cells growth on CAM are usually visible after 5–
7 days after inoculation (on the 12th–14th day of incuba-
tion). In the animal model tumors were firstly visible after
9 days (on the 16th day of incubation) (Balke et al. 2010;
Mangieri et al. 2009), what may suggest a slower growth of
this particular cell line. The new element of the procedure
(our modification) was the use of a video otoscope, which
allowed visualization of the tumor growth relatively non-
invasively without enlarging the ‘windows’ made in the
egg’s shells and without too extensive embryo manipula-
tions. This technique has been developed by our team and it
has been considered as highly effective and minimally in-
vasive method in comparison to other methods described in
subject literature of checking the growth of human cell lines
Fig. 3 Feline fibrosarcoma on
chick embryos on the 16th day
of incubation (photographs
taken by contractor, Welch
Allyn MacroView™ Veterinary
Otoscope 71032, USA)
Fig. 2 Feline vaccine-
associated sarcoma cells stained
for a) vimentin, note a strong
cytoplasmic staining reaction
(brown color), original magni-
fication 400×, b) smooth mus-
cle actin, original magnification
400×, c) desmin, original mag-






Vet Res Commun (2012) 36:227–233 231
in chick embryo chorioallantoic membrane using a micro-
scope with an external source of light (Balke et al. 2010).
The literature about CAM model show many limitations
with observation and photograph documentation of the
tumors growth using standard microscope with external
source of light. In many cases it is impossible to make
photographs without enlarging the “window” in the egg
shell as during embryogenesis silicon rings and tumors are
not always visible in the middle of the window. On the other
hand, in screening experiments contractors have checked
that enlarging the “window” in the egg shell increases the
mortality of chick embryos, probably due to the higher
water permeability making chick embryos dry out. The
video otoscope enables the observation of all tumors despite
their localization without enlarging the “window” in the egg
shell. There are some problems with making high quality
photographs of 3D living organisms, but that does not
depend on the kind of equipment used.
The biggest difficulty that the contractors had to deal with
while performing screening studies was the high mortality of
chick embryos connected with taking out the parchment-like
membrane. Silicon rings were put on CAM on different days
of embryogenesis (5th, 6th, 7th, 8th), noticing the lowest
mortality at 5th day (around 10 %). The highest mortality
was at 8th day reaching nearly 60 %, what was probably due
to mechanical manipulations connected with easier damaging
more developed blood vessels of CAM. This model, when
performed before 11th day of chick embryo incubation, is
Fig. 5 Immunohistochemical labelling of sarcoma: a. Intense
vimentin-cytoplasmic immunostaining in neoplastic cells. Arrowhead
showed a trinucleated neoplastic cell. Peroxidase-based EnVision™kit
(DakoCytomation, Denmark) and hematoxylin counterstain, original
magnification 400×. b. Cytoplasmic positivity of alpha-smooth muscle
actin noted in some neoplastic cells (graph on the left) Peroxidase-
based EnVision™kit (DakoCytomation, Denmark) and hematoxylin
counterstain, original magnification 400×. c. Immunopositivity for
desmin distributed among blood vessels. Peroxidase-based EnVi-
sion™kit (DakoCytomation, Denmark) and hematoxylin counterstain,
original magnification 200×. d. No immunoreactivity with cytokeratin.
Inset: Cytokeratin immune-staining were detected only in small foci of
presumptive squamous epithelial cells within chorioallantois mem-
brane of chicken embryo. Peroxidase-based EnVision™kit (DakoCy-
tomation, Denmark) and hematoxylin counterstain, original
magnification 100×, inset: 400×
Fig. 4 a) Microscopic examination of undifferentiated sarcoma. The
neoplastic cells were arranged in an irregular pattern. Haematoxylin
and eosin stain, original magnification 100×. b) Sarcoma characterized
by neoplastic cells with atypia, eosinophilic cytoplasm and unclear cell
border, some with prominent eosinophilic nucleoli. Haematoxylin and
eosin stain, original magnification 400×. c) Interstitial collagen fibres
(green) separated neoplastic cells were very scant. Masson’s trichome
stain, original magnification 200×
232 Vet Res Commun (2012) 36:227–233
available for xentographs as until this day the immune system
of the chick embryo is immature
As far as we believe, our experiment of the implantation of
the animal cell line on CAMwas a first such study in the field
of veterinary oncology. However, further studies using differ-
ent cell lines are required to use this easy model for investi-
gation of cancer biology and to assess the effectiveness of new
anticancer drugs. Animal models are essential for entering
new therapeutic agents into the market and can not be
avoided. We believe that showing the possibility of first feline
fibrosarcoma cell growth on CAM will encourage other vet-
erinary scientists to further investigate using other animal cell
lines and may be a basis to creating an inexpensive and
relatively easy to use new experimental model.
Open Access This article is distributed under the terms of the Crea-
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